Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 12
Review
Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,914 | Dovepress* | 7,280+ | 210 | 7,490 | |
| PubMed Central* | 2,634 | 381 | 3,015 | ||
| Totals | 9,914 | 591 | 10,505 | ||
| *Since 2 November 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 21 | 0 | 0 | 1 | 8 | 12 |
View citations on PubMed Central and Google Scholar